CORMEDIX INC. Adjustments to Additional Paid in Capital, Warrant Issued
CORMEDIX INC. (CRMD) reported Adjustments to Additional Paid in Capital, Warrant Issued of $128.63 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-30
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-12-31 was $0.00.
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-09-30 was $128.63K.
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-12-31 was $0.00.
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $128.63K, a 21.99% decline from fiscal 2021.
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $164.89K.
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $106.11K.
- CORMEDIX INC. adjustments to additional paid in capital, warrant issued for fiscal 2007 was $748.50K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $128.63K derived: sum of 2 quarters · filed 2023-03-30 | $128.63K 10-K · filed 2023-03-30 | |
| 2022-09-30 | $128.63K 10-Q · filed 2022-11-10 | $128.63K 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $164.89K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $164.89K 10-Q · filed 2022-11-10 | |||
| 2012-12-31 | $106.11K 10-K · filed 2013-03-27 | |||
| 2007-12-31 | $748.50K 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |